Spada M et al. |
Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. |
2006 |
Am. J. Transplant. |
pmid:16771811
|
Saliba F et al. |
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. |
2017 |
Am. J. Transplant. |
pmid:28133906
|
Levitsky J and Feng S |
Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle. |
2014 |
Am. J. Transplant. |
pmid:24620373
|
de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Cavadas PC et al. |
Bilateral trans-humeral arm transplantation: result at 2 years. |
2011 |
Am. J. Transplant. |
pmid:21521475
|
Trofe-Clark J et al. |
Immunosuppression, generic drugs and the FDA. |
2012 |
Am. J. Transplant. |
pmid:22176626
|
Latran M |
Response to Klintmalm on the use of generic immunosuppression. |
2012 |
Am. J. Transplant. |
pmid:22176636
|
Asrani SK et al. |
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. |
2014 |
Am. J. Transplant. |
pmid:24456026
|
Song L et al. |
ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys. |
2017 |
Am. J. Transplant. |
pmid:27598231
|
Egli A et al. |
Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. |
2010 |
Am. J. Transplant. |
pmid:20840474
|
Saikali JA et al. |
Sirolimus may promote thrombotic microangiopathy. |
2003 |
Am. J. Transplant. |
pmid:12603218
|
Sis B et al. |
Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. |
2006 |
Am. J. Transplant. |
pmid:16686769
|
Duncan FJ et al. |
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. |
2007 |
Am. J. Transplant. |
pmid:17941958
|
Hu X et al. |
Chimeric Allografts Induced by Short-Term Treatment With Stem Cell-Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: A Study in Rats. |
2016 |
Am. J. Transplant. |
pmid:26749344
|
Cameron AM et al. |
Chimeric Allografts Induced by Short-Term Treatment With Stem Cell Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: II, Study in Miniature Swine. |
2016 |
Am. J. Transplant. |
pmid:26748958
|
McKenna G and Trotter JF |
Does early (CNI) conversion lead to eternal (renal) salvation? |
2010 |
Am. J. Transplant. |
pmid:20928938
|
Hanto DW et al. |
Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in Swine. |
2010 |
Am. J. Transplant. |
pmid:20977633
|
Al-Massarani G et al. |
Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. |
2008 |
Am. J. Transplant. |
pmid:18925903
|
Frassetto LA and Benet LZ |
Pharmacogenomics and transplantation: where are we? |
2004 |
Am. J. Transplant. |
pmid:15147415
|
Koefoed-Nielsen PB et al. |
Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. |
2002 |
Am. J. Transplant. |
pmid:12099520
|
Willicombe M et al. |
Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. |
2011 |
Am. J. Transplant. |
pmid:21299828
|
Muthusamy AS et al. |
Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation. |
2008 |
Am. J. Transplant. |
pmid:18828772
|
Srinivas TR et al. |
The noninferiority trial: don't don't do it. |
2010 |
Am. J. Transplant. |
pmid:21087412
|
Madariaga ML et al. |
Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma. |
2015 |
Am. J. Transplant. |
pmid:25824550
|
Vanrenterghem Y et al. |
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. |
2005 |
Am. J. Transplant. |
pmid:15636615
|
Sindhi R et al. |
Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early liver rejection. |
2005 |
Am. J. Transplant. |
pmid:15636616
|
Bryan CF et al. |
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. |
2007 |
Am. J. Transplant. |
pmid:17359511
|
Vincenti F et al. |
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. |
2007 |
Am. J. Transplant. |
pmid:17359512
|
Cendales L et al. |
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report. |
2015 |
Am. J. Transplant. |
pmid:25773260
|
Jaksch P et al. |
Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study. |
2014 |
Am. J. Transplant. |
pmid:25039364
|
Asrani SK and O'Leary JG |
Can one pill a day keep rejection away? |
2015 |
Am. J. Transplant. |
pmid:25703394
|
Bhorade SM et al. |
Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. |
2003 |
Am. J. Transplant. |
pmid:14629288
|
Pondrom S |
The AJT report. |
2008 |
Am. J. Transplant. |
pmid:18324976
|
Chodoff L and Hamberg KJ |
Response to 'Different preparations of tacrolimus and medication errors'. |
2009 |
Am. J. Transplant. |
pmid:19392982
|
Barth RN et al. |
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. |
2011 |
Am. J. Transplant. |
pmid:21668624
|
Guirado L et al. |
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21668633
|
Flechner SM et al. |
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. |
2011 |
Am. J. Transplant. |
pmid:21668635
|
Budde K |
How to use mTOR inhibitors? The search goes on. |
2011 |
Am. J. Transplant. |
pmid:21668636
|
Maes BD et al. |
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12484345
|
Schrepfer S et al. |
Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease. |
2007 |
Am. J. Transplant. |
pmid:17532751
|
Asberg A et al. |
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20486914
|
Hautz T et al. |
Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. |
2010 |
Am. J. Transplant. |
pmid:20353468
|
Pallet N et al. |
Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. |
2015 |
Am. J. Transplant. |
pmid:25588704
|
Min SI et al. |
Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy. |
2013 |
Am. J. Transplant. |
pmid:23734831
|
Chamie K et al. |
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. |
2008 |
Am. J. Transplant. |
pmid:18853950
|
Lefaucheur C et al. |
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. |
2008 |
Am. J. Transplant. |
pmid:18671673
|
Haufroid V et al. |
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. |
2006 |
Am. J. Transplant. |
pmid:17049058
|
Lake JR et al. |
Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation. |
2005 |
Am. J. Transplant. |
pmid:16303011
|
Margreiter R et al. |
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. |
2008 |
Am. J. Transplant. |
pmid:18510632
|
Mandelbrot DA et al. |
Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus. |
2015 |
Am. J. Transplant. |
pmid:26176342
|